BAM
KRTX

Bellevue Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bellevue Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$1.27K – 468
2023
Q4 		$1.27K Buy
+4
New +$778 ﹤0.01% 442

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bellevue Asset Management's KRTX Position: Q1 2024 in Review

Bellevue Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4 shares — an estimated $1.27K sold.

Bellevue Asset Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.27K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Bellevue Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bellevue Asset Management sold 4 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.27K.
  • Bellevue Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Bellevue Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.27K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bellevue Asset Management's 13F filing for Q1 2024, filed 26 Apr 2024.